Peter Dynoodt
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer.
Journal: Clinical chemistry
Published: September 30, 2021
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 15, 2021
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma.
Journal: Cell death & disease
Published: December 05, 2019
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 01, 2019
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer.
Journal: Oncotarget
Published: November 08, 2016
Prognostic and predictive biomarkers in melanoma: an update.
Journal: Expert review of molecular diagnostics
Published: December 02, 2015
miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Journal: International journal of oncology
Published: October 17, 2012
Identification of miR-145 as a key regulator of the pigmentary process.
Journal: The Journal of investigative dermatology
Published: August 17, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026